A Targeted Approach
In order to develop a Point-of-Care tool, various technologies including molecular medicine, nanobiotechnology, microfluidics, material sciences and biochemistry come together.
Development – integrate proteomics and genomics technology into a functional single PoC device
Clinical validation – comparing the PoCOSteo results with those of the current state-of-the-art of each technology separately
Commercialisation – preparation for commercialisation of a Point-of-Care tool for bone disease assessment
To realize this objective a balanced consortium of research partners and SME’s has been brought together, and a well-considered and logical work plan devised.
The proof of concept of different parts of the final device are already designed in the lab
Integrate proteomics and genomics technology into a functional single PoC device
Comparing the PoCOsteo results with those of the current state-of-the-art of each technology separately
Preparation for commercialisation of the tool to identify individuals at high-risk of osteoporosis and osteoporotic fracture.
Press releases, Papers, abstracts, public presentations,…
Special thanks to
The PoCOsteo project is receiving funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 676325.
The project is supported and advised by the IOF, the International Osteoporosis Foundation, which is the main global alliance of patient societies, research organizations, healthcare professionals and international companies working to promote bone, muscle and joint health.